We are dedicated to enhancing brain health worldwide by delivering science-based, natural supplements that protect, nourish, and empower your mind.
 

Previously, drug testing in mouse models was slow, expensive, and incomplete, taking over a year to evaluate a single drug.

Alzheimer’s-in-a-Dish™ allows for rapid and efficient screening of drugs and natural products, cutting drug discovery time and cost by 100-fold.

Since 2014, this model has been used to test over 1,700 FDA-approved drugs and over 3,500 natural products thanks to funding from the Cure Alzheimer’s Fund (curealz.org) to Massachusetts General Hospital, enabling the license of the intellectual property leading to the formulation of CogniSHIELD.

This has led to the discovery of more than 50 unique, synergistic and multi-functional combinations of safe drugs and natural products that significantly reduce beta-amyloid, tau tangles, and neuroinflammation, all of which harm the brain.

With these safe and effective candidates identified, the next step is human clinical trials to measure beta-amyloid levels in the blood, confirm brain penetration, and evaluate reductions in pathology.

Thanks to their well-established safety profiles, successful combinations can be fast-tracked for market development, offering new hope in the fight to address age-related cognitive decline.